Estevan Antonio Romero, | |
802 3rd Street, Springer, NM 87747 | |
(505) 398-1567 | |
(575) 383-3337 |
Full Name | Estevan Antonio Romero |
---|---|
Gender | Male |
Speciality | Community Health Worker |
Location | 802 3rd Street, Springer, New Mexico |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053994962 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | (* (Not Available)) | Secondary |
172V00000X | Community Health Worker | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Estevan Antonio Romero, Po Box 446, Springer, NM 87747-0446 Ph: (505) 398-1567 | Estevan Antonio Romero, 802 3rd Street, Springer, NM 87747 Ph: (505) 398-1567 |
News Archive
Two forms of skin and brain cancer respond very poorly to chemotherapy and radiation: melanoma and glioblastoma multiforme brain cancer.
The American Medical Group Association (AMGA), a trade association representing multispecialty medical groups and other organized systems of care, today released its comments on the CMS Request for Information on Accountable Care Organizations (ACOs). The comments were due and submitted on December 3, 2010. CMS has announced that the notice of proposed rulemaking on ACOs will be published early next year
Jubilant Organosys Limited, an integrated pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company out of India, today announced the repayment of FCCBs amounting to US$ 50 million along with the YTM of US$ 19 million. The FCCBs were due for redemption on May 24, 2010.
Financial support for population-related activities worldwide has not significantly increased since 2008, according to a report (.pdf) from U.N. Secretary-General Ban Ki-moon to the U.N. Commission on Population and Development (CPD), Inter Press Service reports. The CPD is meeting this week.
Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible.
› Verified 6 days ago